Skip to main content
Amvuttra Coupon - Amvuttra 0.5ml prefilled syringe of 25mg/0.5ml carton

Amvuttra

vutrisiran
Used for Hereditary Transthyretin-Mediated Amyloidosis
Used for Hereditary Transthyretin-Mediated Amyloidosis

Amvuttra (vutrisiran) is a prescription injection used to treat nerve damage (polyneuropathy) in adults with a rare condition called hereditary transthyretin-mediated amyloidosis (hATTR). It's also FDA approved to treat heart muscle problems (cardiomyopathy) in adults with either wild-type transthyretin-mediated amyloidosis (ATTRwt) or hATTR. This medication belongs to a drug class called small interfering ribonucleic acids (siRNAs) and is injected under the skin once every 3 months by a healthcare professional. Some common side effects include joint pain and shortness of breath.

Last reviewed on September 30, 2025
basics-icon

What is Amvuttra (vutrisiran)?

What is Amvuttra (vutrisiran) used for?

How Amvuttra (vutrisiran) works

Amvuttra (vutrisiran) is a small interfering ribonucleic acid (siRNA). It works by blocking the genetic message (mRNA) that tells your body to make a harmful protein called transthyretin (TTR). When too much TTR builds up, it can form clumps that damage your nerves and heart. By lowering TTR levels, Amvuttra (vutrisiran) helps reduce nerve damage and heart muscle problems.

When does Amvuttra (vutrisiran) start working?
Time passed since treatment started:
HOURS
DAYS
WEEKS
MONTHS
Initial effect
Full effect

Drug Facts

Common BrandsAmvuttra
Drug ClassSmall interfering ribonucleic acid (siRNA)
Controlled Substance ClassificationNot a controlled medication
Generic StatusNo lower-cost generic available
AvailabilityPrescription only
basics-icon

What are the side effects of Amvuttra (vutrisiran)?

The following side effects may get better over time as your body gets used to the medication. Let your healthcare provider know immediately if you continue to experience these symptoms or if they worsen over time.

Common Side Effects

  • Pain in arms and legs (15%)
  • Joint pain (11%)
  • Shortness of breath (7%)
  • Lower vitamin A levels (7%)

Other Side Effects

When do Amvuttra (vutrisiran) possible side effects begin and end?
Time passed since treatment started:
MINUTES
HOURS
DAYS
WEEKS
MONTHS
Injection-site reactions

Source: DailyMed

The following side effects have also been reported

Side effects that you should report to your care team as soon as possible:

Side effects that usually do not require medical attention (report these to your care team if they continue or are bothersome):

  • Joint pain
  • Pain, redness, or irritation at injection site
  • Pain in the hands or feet
pros-and-cons

Pros and cons of Amvuttra (vutrisiran)

thumbs-up

Pros

Injected once every 3 months

Given under the skin, instead of through the veins

Doesn't require pretreatment medications

Treats both nerve and heart problems from ATTR

thumbs-down

Cons

Likely to cause low vitamin A levels

Needs to be given by a healthcare professional

Unknown if safe or works well in children

Maybe not safe during pregnancy

pharmacist-tips

Pharmacist tips for Amvuttra (vutrisiran)

pharmacist
  • Amvuttra (vutrisiran) is injected under the skin in your stomach, thighs, or upper arms by a healthcare professional every 3 months. Mark your appointments on a calendar so you don’t forget.

    • If you miss a dose of Amvuttra (vutrisiran), contact your prescriber as soon as possible to reschedule your appointment. Your next doses should then be scheduled every 3 months from that date.

      • Amvuttra (vutrisiran) can lower the amount of vitamin A in your blood. So your prescriber might recommend that you take a vitamin A supplement every day.

        • Tell your prescriber right away if you notice any vision changes, such as night blindness, dry eyes, cloudy corneas, or new spots in your vision. These might be signs that your vitamin A levels are too low.

          • Don't take more vitamin A than what your prescriber recommends. Too much vitamin A can cause symptoms such as severe headache, nausea, dizziness, and muscle aches.

            • Amvuttra (vutrisiran) hasn’t been studied in pregnant women, but animal studies show it could harm unborn babies. And since this medication can also lower vitamin A levels, it might also affect the baby's development. If you’re pregnant or planning to become pregnant, talk with your prescriber about the risks and benefits of taking this medication.

              faqs

              Frequently asked questions about Amvuttra (vutrisiran)

              How long does it take for Amvuttra (vutrisiran) to work?
              In clinical studies, Amvuttra (vutrisiran) lowered TTR protein levels after the first dose. Most people had lower TTR levels within 3 weeks after starting treatment. Even though Amvuttra (vutrisiran) starts working quickly to reduce TTR levels, it can take longer to notice changes in your symptoms. By around 9 months, many people with nerve problems had improvement in nerve function.
              Does Amvuttra (vutrisiran) help neuropathy?
              Yes, Amvuttra (vutrisiran) can help treat neuropathy (nerve damage) caused by hATTR. In a clinical study, 48% of people who took Amvuttra (vutrisiran) recovered some nerve function after 18 months, compared with only 4% of people who received placebo.
              When was Amvuttra (vutrisiran) approved?
              Amvuttra (vutrisiran) was first FDA approved in June 2022 for nerve damage in adults with hATTR. In March 2025, it received another approval for treating heart muscle problems in adults with either ATTRwt or hATTR.
              Who makes Amvuttra (vutrisiran)?
              Amvuttra (vutrisiran) is made by Alnylam Pharmaceuticals, Inc.
              What's the difference between Amvuttra (vutrisiran) and Onpattro (patisiran)?
              Amvuttra (vutrisiran) and Onpattro (patisiran) are both used to treat nerve damage in people with hATTR, but they differ in how they're given and their side effects. Amvuttra (vutrisiran) is injected under the skin once every 3 months, while Onpattro (patisiran) is infused into the veins once every 3 weeks. Both medications can cause low vitamin A levels, but Onpattro (patisiran) is more likely to cause infusion-related reactions and upper respiratory infections like the common cold. Talk with your healthcare professional if you have questions about comparing the two.
              How does Amvuttra (vutrisiran) differ from tafamidis?
              Both Amvuttra (vutrisiran) and Vyndaqel (tafamidis) are used to treat adults with heart muscle problems (cardiomyopathy) caused by ATTRwt or hATTR, but they have some differences. Tafamidis comes as an oral capsule under two brand names: Vyndaqel and Vyndamax.Amvuttra (vutrisiran) is only available as an injection. The dosing is also different. Follow up with your healthcare professional to learn about other differences and which option might be best for you.
              GoodRxEducationalIcon

              How to save using GoodRx

              Compare Prices
              1. Compare PricesSpecify your dosage and quantity to find out exactly how much you can save.
              Select your free coupon
              2. Select your free couponYou can use the displayed coupon, or compare prices at other pharmacies near you.
              Show coupon to your pharmacist
              3. Show coupon to your pharmacistPresent your printed or electronic coupon when you pick up your prescription.
              Get free couponLearn more
              warings-icon

              What are the risks and warnings for Amvuttra (vutrisiran)?

              Amvuttra (vutrisiran) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.

              risk-warning

              Low vitamin A levels

              Amvuttra (vutrisiran) can lower the vitamin A in your blood, which might cause problems like poor night vision and raise your risk of infections. Your prescriber might recommend a vitamin A supplement while you're taking this medication. But don't take more than directed since too much vitamin A causes severe headache, nausea, dizziness, and muscle aches. Let your care team know if you notice blurry vision or trouble seeing at night because these can be signs of low vitamin A.

              dosage

              Amvuttra (vutrisiran) dosage forms

              Typical dosing for Amvuttra (vutrisiran)

              The typical dose is 25 mg injected under the skin by a healthcare professional once every 3 months.

              alternatives

              What are alternatives to Amvuttra (vutrisiran)?

              There are a number of medications that your doctor can prescribe in place of Amvuttra (vutrisiran). Compare a few possible alternatives below.
              Amvuttra (vutrisiran)
              Used for:
              Used for:
              • Polyneuropathy from hereditary transthyretin-mediated amyloidosis (hATTR)

              Used for:
              • Polyneuropathy from hereditary transthyretin-mediated amyloidosis (hATTR)

              images

              Amvuttra (vutrisiran) images

              yellow - Amvuttra 25mg / 0.5mL Pre-Filled Syringe Solution for Injection
              This medicine is Yellow Carton.yellow - Amvuttra 25mg / 0.5mL Pre-Filled Syringe Solution for Injection

              Get savings updates for Amvuttra (vutrisiran)

              Receive price alerts, news, and other messages from GoodRx about Amvuttra (vutrisiran) and other healthcare topics and relevant savings offers.

              By providing your email, you consent to receive marketing communications from GoodRx, which may include content and/or data related to men’s health, women's health, reproductive care, or sexual health. You agree to the GoodRx Terms of Use and acknowledge the Privacy Policy. You can unsubscribe at any time.

              Browse medications

              View All

              Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.